- Home
- IVDA vs XXII Comparison
IVDA vs XXII Comparison
Compare IVDA & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- XXII
- Stock Information
- Founded
- IVDA 2003
- XXII 1998
- Country
- IVDA United States
- XXII United States
- Employees
- IVDA N/A
- XXII N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- XXII Medicinal Chemicals and Botanical Products
- Sector
- IVDA Technology
- XXII Health Care
- Exchange
- IVDA Nasdaq
- XXII Nasdaq
- Market Cap
- IVDA 3.7M
- XXII 4.0M
- IPO Year
- IVDA N/A
- XXII N/A
- Fundamental
- Price
- IVDA $1.40
- XXII $0.09
- Analyst Decision
- IVDA
- XXII
- Analyst Count
- IVDA 0
- XXII 0
- Target Price
- IVDA N/A
- XXII N/A
- AVG Volume (30 Days)
- IVDA 213.5K
- XXII 9.6M
- Earning Date
- IVDA 11-25-2024
- XXII 11-12-2024
- Dividend Yield
- IVDA N/A
- XXII N/A
- EPS Growth
- IVDA N/A
- XXII N/A
- EPS
- IVDA N/A
- XXII N/A
- Revenue
- IVDA $5,305,154.00
- XXII $9,918,000.00
- Revenue This Year
- IVDA $23.76
- XXII $56.94
- Revenue Next Year
- IVDA $229.89
- XXII $2.98
- P/E Ratio
- IVDA N/A
- XXII $0.03
- Revenue Growth
- IVDA N/A
- XXII N/A
- 52 Week Low
- IVDA $1.27
- XXII $0.09
- 52 Week High
- IVDA $10.16
- XXII $5.28
- Technical
- Relative Strength Index (RSI)
- IVDA 43.18
- XXII 31.38
- Support Level
- IVDA $1.27
- XXII $0.09
- Resistance Level
- IVDA $1.56
- XXII $0.13
- Average True Range (ATR)
- IVDA 0.22
- XXII 0.01
- MACD
- IVDA 0.01
- XXII 0.01
- Stochastic Oscillator
- IVDA 20.00
- XXII 10.51
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.